Galaxy Surfact.
Galaxy Surfact. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
2 of 4 strong
Not discussed on this call: fundraise.
The short version
Volume growth guidance maintained at 6% to 8% for full year FY26-27. Galaxy Surfactants expects volume growth of 6% to 8% annually going forward.
From Galaxy Surfact.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Volume growth guidance maintained at 6% to 8% for full year FY26-27.
- Confident of sustaining 6% to 7% average volume growth beyond Q3-Q4 despite AMET market challenges.
- India region expected to continue strong volume growth, driven by rural demand and premiumization.
- Specialty ingredients and performance surfactants businesses both targeted for growth—no shift away from either.
- New specialty products pipeline expected to contribute over 5% of total revenue and margins by 2030.
- Inorganic growth pursued cautiously with acquisitions under evaluation, aiming for strategic fit and profitability accretion.
- AMET volumes to recover from supply constraints, with diversification into other countries offsetting local market churn.
- EBITDA per ton guidance raised to INR 24,000-25,000, reflecting improved product mix, operational excellence, and price gains.
Profitability & Margins
See what Galaxy Surfact. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Galaxy Surfactants plans a capex of about INR 150 crores for the current year, similar to the previous year.
- Some capex has already been front-loaded and commissioned, with the remainder to be commissioned this year.
- Capex is aimed at capacity expansions, including debottlenecking exercises, and preparing for anticipated business growth.
- There is a focus on growing both performance and specialty chemical segments.
- Inorganic growth via M&A is actively being evaluated; managment is seeking the right fit aligned with strategy and profitability.
- No planned acquisitions in the AMET market currently; any inorganic moves will be accretive and strategic.
- EPC project in Mexico is progressing as planned, with commercialization expected in the next 12 months.
- Significant ongoing innovation investments underpin the Strategy 2030 growth agenda.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Galaxy Surfact. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly disclose the current or expected order book or pending orders of Galaxy Surfactants Limited.
- However, it is mentioned that in the U.S. market, customer approvals and project approvals have started falling in place, indicating an improving order pipeline.
- The management highlighted good customer acceptance and project momentum, especially for new products like TRI-K and Everbond in the U.S. market.
- The momentum in demand remains healthy across key markets including India, U.S., and APAC.
- The company is closely monitoring supply chain and geopolitical developments that could impact order execution.
- They are confident of sustaining volume growth of 6%-8% in the near term.
- No specific quantification of order backlog or pending orders was provided in the call.
Galaxy Surfact. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.3K Cr, net profit ₹62 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Galaxy Surfactants Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Solar Industries India Ltd (Q1 FY27)
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Chemicals Ltd (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF Ltd (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
Frequently Asked Questions
What were Galaxy Surfact. Q1 FY27 results?
Volume growth guidance maintained at 6% to 8% for full year FY26-27. Galaxy Surfactants expects volume growth of 6% to 8% annually going forward.
What is Galaxy Surfact. share price analysis?
Galaxy Surfact. currently shows a neutral. The stock trades at a P/E of 22.8 with a market cap of ₹8,272 Cr. Investors should review the full earnings analysis for detailed insights.
Is Galaxy Surfact. planning capital expenditure?
Galaxy Surfactants plans a capex of about INR 150 crores for the current year, similar to the previous year.
Keep Galaxy Surfact. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.